Form 4: Aura Biosciences SVP of Finance, Amy Elazzouzi, Sells Shares to Cover Tax Obligations

Amy Elazzouzi, Senior Vice President of Finance at Aura Biosciences, sold 897 shares of common stock to cover tax withholding obligations related to vesting restricted stock units.

Summary

• On April 16, 2025, Amy Elazzouzi, Senior Vice President of Finance at Aura Biosciences, sold 897 shares of the company's common stock.
• The sale was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
• The shares were sold at a weighted average price of $5.49, with individual transactions ranging from $5.49 to $5.57.
• Following the transaction, Elazzouzi directly owns 81,381 shares of Aura Biosciences common stock.

Sentiment

Score: 5

Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't necessarily reflect a positive or negative outlook on the company.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates a sale of shares to cover tax obligations, which is a common practice.

Stakeholder Impact

• The sale of shares by a company insider can sometimes create short-term selling pressure, but this transaction is unlikely to have a significant impact on shareholders due to its nature and relatively small size.

Key Dates

Keywords

Aura Biosciences, Form 4, SEC Filing, Stock Sale, Insider Trading, Amy Elazzouzi, Tax Obligations, Restricted Stock Units